Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operating Overview
Go back to Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operating Overview| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 21.09 -0.3 (1.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.39 | 52 Week High | $42.49 | |||
| Open | $21.49 | 52 Week Low | $16.64 | |||
| Day High | $21.55 | P/E | N/A | |||
| Day Low | $21.05 | EPS | $-0.42 | |||
| Volume | 753,938 | |||||
